Stepwise progression of beta-selection during T cell development involves histone deacetylation
Journal Title
Life Science Alliance
Publication Type
Research article
Abstract
During T cell development, the first step in creating a unique T cell receptor (TCR) is genetic recombination of the TCRbeta chain. The quality of the new TCRbeta is assessed at the beta-selection checkpoint. Most cells fail this checkpoint and die, but the coordination of fate at the beta-selection checkpoint is not yet understood. We shed new light on fate determination during beta-selection using a selective inhibitor of histone deacetylase 6, ACY1215. ACY1215 disrupted the beta-selection checkpoint. Characterising the basis for this disruption revealed a new, pivotal stage in beta-selection, bookended by up-regulation of TCR co-receptors, CD28 and CD2, respectively. Within this "DN3b(Pre)" stage, CD5 and Lef1 are up-regulated to reflect pre-TCR signalling, and their expression correlates with proliferation. These findings suggest a refined model of beta-selection in which a coordinated increase in expression of pre-TCR, CD28, CD5 and Lef1 allows for modulating TCR signalling strength and culminates in the expression of CD2 to enable exit from the beta-selection checkpoint.
Publisher
Life Science Alliance
Keywords
*CD28 Antigens/genetics/metabolism; *Receptors, Antigen, T-Cell, alpha-beta/genetics; Histones/metabolism; Histone Deacetylase 6/metabolism; T-Lymphocytes/metabolism; Receptors, Antigen, T-Cell/metabolism
Department(s)
Laboratory Research
PubMed ID
36283704
Open Access at Publisher's Site
https://doi.org/10.26508/lsa.202201645
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-04-04 06:09:39
Last Modified: 2023-04-17 11:53:04

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙